SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-002951
Filing Date
2023-01-06
Accepted
2023-01-06 07:01:04
Documents
14
Period of Report
2023-01-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d423520d8k.htm   iXBRL 8-K 32737
2 EX-99.1 d423520dex991.htm EX-99.1 8614
6 GRAPHIC g423520g0106064822007.jpg GRAPHIC 3645
  Complete submission text file 0001193125-23-002951.txt   171222

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bioc-20230106.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bioc-20230106_lab.xml EX-101.LAB 17234
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bioc-20230106_pre.xml EX-101.PRE 10811
8 EXTRACTED XBRL INSTANCE DOCUMENT d423520d8k_htm.xml XML 3266
Mailing Address 9955 MESA RIM ROAD SAN DIEGO CA 92121
Business Address 9955 MESA RIM ROAD SAN DIEGO CA 92121 858-320-8200
BIOCEPT INC (Filer) CIK: 0001044378 (see all company filings)

IRS No.: 800943522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36284 | Film No.: 23513736
SIC: 8071 Services-Medical Laboratories